Brief: Oric Pharmaceuticals Reports Fourth Quarter Loss Per Share Of $0.58
21/03/2022 20:02
March 21 (Reuters) - Oric Pharmaceuticals Inc ORIC.O :
* ORIC PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR
2021 FINANCIAL RESULTS AND OPERATIONAL UPDATE
* ORIC PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.58
Source text for Eikon: ID:nGNX8Xq948
Further company coverage: ORIC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ORIC Pharmaceuticals
See all newsBrief: Oric® Pharmaceuticals Announces Agreement With Cancer Research UK
ORIC Pharmaceuticals Q1 net loss widens on higher R&D costs
Brief: ORIC Pharmaceuticals Q1 Operating Expenses USD 39.619 Million
Brief: Oric Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
ORIC Pharmaceuticals Q4 loss narrows